WASHINGTON — The U.S. Department of Health and Human Services announced sweeping restrictions on gender treatments for minors Thursday. The proposed regulatory actions involve the HHS, Food and Drug ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump said Friday he’s ...

President Donald Trump holds up a chart of "reciprocal tariffs" while speaking during a “Make America Wealthy Again” trade announcement event in April. (Credit: Chip Somodevilla/Getty Images) The ...

‘Unforgivable under any circumstances’: Sen. Murphy responds to analysis that US likely responsible for Iran school strike ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

TAMPA, Fla. — HOA attorney Eric Glazer often has a lengthy line of attendees at his booth at the Tampa Bay Condo & HOA Expo. But at this expo, the questions kept coming. It’s no surprise, especially ...

From small publishers to US federal agencies, websites are reporting unusual spikes in automated traffic linked to IP addresses in Lanzhou, China. When he first noticed the traffic spike, Quintero ...

As the software sector got battered for an eighth straight session Thursday, the losses were widespread. Of the 114 stocks in the iShares Expanded Tech-Software ETF IGV, there were 102 decliners, ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...

Despite weaker-than-expected interim numbers, CSL maintains “ambitious” full-year guidance. But investors are sceptical Rhythm Biosciences enlists its first prescriber for its Colostat bowel cancer ...

Good afternoon, everyone, and thank you for joining us on short notice. My name is Mark Dehring, Head of Investor Relations at CSL. The focus of today's call is CSL's leadership transition, and we ...

With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the eve of its latest earnings announcement. Paul McKenzie, Ph.D., who’s served ...